Skip to main content
Top
Published in: CEN Case Reports 1/2018

01-05-2018 | Case Report

A novel heterozygous GLI2 mutation in a patient with congenital urethral stricture and renal hypoplasia/dysplasia leading to end-stage renal failure

Authors: Toshihiko Shirakawa, Yumiko Nakashima, Satoshi Watanabe, Sadatomo Harada, Mariko Kinoshita, Toshiharu Kihara, Yuko Hamasaki, Seiichiro Shishido, Koh-ichiro Yoshiura, Hiroyuki Moriuchi, Sumito Dateki

Published in: CEN Case Reports | Issue 1/2018

Login to get access

Abstract

Glioblastoma 2 (GLI2) is a mediator of Sonic hedgehog signaling pathway that plays an important role in development of the central nervous system and limbs. Heterozygous GLI2 mutations have been associated with postaxial polydactyly, various pituitary dysfunction, and holoprosencephaly-like phenotype. Herein, we report a Japanese boy who presented with isolated growth hormone deficiency with ectopic posterior pituitary, postaxial polydactyly, atrioventricular septal defect, intellectual disability and dysmorphic facial features including mid-facial hypoplasia. The patient was also complicated with congenital urethral stricture with megacystis, hydronephrosis, and renal hypoplasia/dysplasia, which led to end-stage renal failure by the age of 8 years. Trio-whole-exome sequencing showed a novel de novo heterozygous frameshift mutation in GLI2 (c.3369delG, p.Met1123Ilefs*7) in the patient. This is the first report of possible association between GLI2 mutation and the phenotype of congenital anomalies of the kidney and urinary tract, and subsequent end-stage renal failure. Further studies on the urogenital phenotype in patients with GLI2 mutations may clarify a role of GLI2 in embryonic development of the urinary tract.
Literature
1.
go back to reference Ruiz i Altaba A, Palma V, Dahmane N. Hedgehog-Gli signalling and the growth of the brain. Nat Rev Neurosci. 2002;3:24–33.CrossRefPubMed Ruiz i Altaba A, Palma V, Dahmane N. Hedgehog-Gli signalling and the growth of the brain. Nat Rev Neurosci. 2002;3:24–33.CrossRefPubMed
2.
go back to reference Roessler E, Du YZ, Mullor JL, Casas E, Allen WP, Gillessen-Kaesbach G, Roeder ER, Ming JE, Ruiz i Altaba A, Muenke M. Loss-of-function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosencephaly-like features. Proc Natl Acad Sci USA. 2003;100:13424–9.CrossRefPubMedPubMedCentral Roessler E, Du YZ, Mullor JL, Casas E, Allen WP, Gillessen-Kaesbach G, Roeder ER, Ming JE, Ruiz i Altaba A, Muenke M. Loss-of-function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosencephaly-like features. Proc Natl Acad Sci USA. 2003;100:13424–9.CrossRefPubMedPubMedCentral
3.
go back to reference Arnhold IJ, França MM, Carvalho LR, Mendonca BB, Jorge AA. Role of GLI2 in hypopituitarism phenotype. J Mol Endocrinol. 2015;54:R141–R50.CrossRefPubMed Arnhold IJ, França MM, Carvalho LR, Mendonca BB, Jorge AA. Role of GLI2 in hypopituitarism phenotype. J Mol Endocrinol. 2015;54:R141–R50.CrossRefPubMed
4.
6.
go back to reference Holbrook JA, Neu-Yilik G, Hentze MW, Kulozik AE. Nonsense-mediated decay approaches the clinic. Nat Genet. 2004;36:801–8.CrossRefPubMed Holbrook JA, Neu-Yilik G, Hentze MW, Kulozik AE. Nonsense-mediated decay approaches the clinic. Nat Genet. 2004;36:801–8.CrossRefPubMed
7.
go back to reference Bear KA, Solomon BD, Antonini S, Arnhold IJ, França MM, Gerkes EH, Grange DK, Hadley DW, Jääskeläinen J, Paulo SS, Rump P, Stratakis CA, Thompson EM, Willis M, Winder TL, Jorge AA, Roessler E, Muenke M. Pathogenic mutations in GLI2 cause a specific phenotype that is distinct from holoprosencephaly. J Med Genet. 2014;51:413–8.CrossRefPubMed Bear KA, Solomon BD, Antonini S, Arnhold IJ, França MM, Gerkes EH, Grange DK, Hadley DW, Jääskeläinen J, Paulo SS, Rump P, Stratakis CA, Thompson EM, Willis M, Winder TL, Jorge AA, Roessler E, Muenke M. Pathogenic mutations in GLI2 cause a specific phenotype that is distinct from holoprosencephaly. J Med Genet. 2014;51:413–8.CrossRefPubMed
8.
go back to reference Miyagawa S, Matsumaru D, Murashima A, Omori A, Satoh Y, Haraguchi R, Motoyama J, Iguchi T, Nakagata N, Hui CC, Yamada G. The role of sonic hedgehog-Gli2 pathway in the masculinization of external genitalia. Endocrinology. 2011;152:2894–903.CrossRefPubMedPubMedCentral Miyagawa S, Matsumaru D, Murashima A, Omori A, Satoh Y, Haraguchi R, Motoyama J, Iguchi T, Nakagata N, Hui CC, Yamada G. The role of sonic hedgehog-Gli2 pathway in the masculinization of external genitalia. Endocrinology. 2011;152:2894–903.CrossRefPubMedPubMedCentral
9.
go back to reference Samnakay N, Orford J, Barker A, Charles A, Terry P, Newnham J, Moss T. Timing of morphologic and apoptotic changes in the sheep fetal kidney in response to bladder outflow obstruction. J Pediatr Urol. 2006;2:216–24.CrossRefPubMed Samnakay N, Orford J, Barker A, Charles A, Terry P, Newnham J, Moss T. Timing of morphologic and apoptotic changes in the sheep fetal kidney in response to bladder outflow obstruction. J Pediatr Urol. 2006;2:216–24.CrossRefPubMed
10.
go back to reference Haecker FM, Wehrmann M, Hacker HW, Stuhldreier G, von Schweinitz D. Renal dysplasia in children with posterior urethral valves: a primary or secondary malformation? Pediatr Surg Int. 2002;18:119–22.CrossRefPubMed Haecker FM, Wehrmann M, Hacker HW, Stuhldreier G, von Schweinitz D. Renal dysplasia in children with posterior urethral valves: a primary or secondary malformation? Pediatr Surg Int. 2002;18:119–22.CrossRefPubMed
11.
go back to reference Kitagawa H, Pringle KC, Koike J, Zuccollo J, Nakada K. Different phenotypes of dysplastic kidney in obstructive uropathy in fetal lambs. J Pediatr Surg. 2001;36:1698–703.CrossRefPubMed Kitagawa H, Pringle KC, Koike J, Zuccollo J, Nakada K. Different phenotypes of dysplastic kidney in obstructive uropathy in fetal lambs. J Pediatr Surg. 2001;36:1698–703.CrossRefPubMed
Metadata
Title
A novel heterozygous GLI2 mutation in a patient with congenital urethral stricture and renal hypoplasia/dysplasia leading to end-stage renal failure
Authors
Toshihiko Shirakawa
Yumiko Nakashima
Satoshi Watanabe
Sadatomo Harada
Mariko Kinoshita
Toshiharu Kihara
Yuko Hamasaki
Seiichiro Shishido
Koh-ichiro Yoshiura
Hiroyuki Moriuchi
Sumito Dateki
Publication date
01-05-2018
Publisher
Springer Japan
Published in
CEN Case Reports / Issue 1/2018
Electronic ISSN: 2192-4449
DOI
https://doi.org/10.1007/s13730-018-0302-9

Other articles of this Issue 1/2018

CEN Case Reports 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.